sellWeak
Michael Greiner sold $153k of AVNS
SVP - Chief Financial Officer at AVANOS MEDICAL, INC.. 8,000 shares at an average of $19.12, traded Mar 14, 2024, filed Mar 15, 2024.
Warning score
33Value
$153k
8,000 shares
Holdings after
151,495
-5% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- +11Trade size$153k at market
- 0Share of holdings soldSold 5.0% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001606498-24-000045, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 14, 2024 | SOpen-market sale Common Stock | -3,800 | $19.11 | $73k | 155,695 | Mar 15, 2024 |
| Mar 14, 2024 | SOpen-market sale Common Stock | -714 | $19.12 | $14k | 154,981 | Mar 15, 2024 |
| Mar 14, 2024 | SOpen-market sale Common Stock | -2,231 | $19.13 | $43k | 152,750 | Mar 15, 2024 |
| Mar 14, 2024 | SOpen-market sale Common Stock | -337 | $19.14 | $6,450 | 152,413 | Mar 15, 2024 |
| Mar 14, 2024 | SOpen-market sale Common Stock | -808 | $19.15 | $15k | 151,605 | Mar 15, 2024 |
| Mar 14, 2024 | SOpen-market sale Common Stock | -110 | $19.16 | $2,108 | 151,495 | Mar 15, 2024 |
Related signals
Other insiders at AVANOS MEDICAL, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | AVNSsell AVANOS MEDICAL, INC. | Kerr Holbrook SVP, Chief Commercial Officer | $165k 15,000 shares | -15% | |
| 45Moderate | AVNSbuy AVANOS MEDICAL, INC. | Gary Blackford director | $659k 60,000 shares | +84% | |
| 25Weak | AVNSsell AVANOS MEDICAL, INC. | Kerr Holbrook SVP, Chief Commercial Officer | $107k 7,000 shares | -8% | |
| 15Weak | AVNSbuy AVANOS MEDICAL, INC. | Julie Ann Shimer director | $9,925 500 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.